301263SZSE

Notice on the Proposal to Repurchase Company Shares by the Controlling Shareholder, Actual Controller, and Chairman

Guangdong Taienkang Pharmaceutical Co., Ltd.·June 4, 2026·3 pages

✨ AI Summary

The controlling shareholder and chairman of Guangdong Tainkang Pharmaceutical Co., Ltd., Mr. Zheng Hanjie, proposed a share repurchase to enhance shareholder value and investor confidence. The repurchase will involve using self-raised funds to buy back a portion of the company's A-shares, with a total amount between RMB 100 million and RMB 200 million. The plan will be executed within three months after board approval.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Securities Code: 301263

Securities Abbreviation: Tainkang

Announcement Number: 2026-055

Guangdong Tainkang Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") recently received a letter from Mr. Zheng Hanjie, the Company's controlling shareholder, actual controller, and chairman, titled "Proposal for Guangdong Tainkang Pharmaceutical Co., Ltd. to Repurchase Company Shares." Mr. Zheng Hanjie proposed that the Company use its own funds and self-raised funds to repurchase a portion of the issued ordinary shares (A-shares) through the centralized bidding trading method on the Shenzhen Stock Exchange. The specific details are as follows:

1. Basic Information of the Proposer and Proposal Date

Proposer: Mr. Zheng Hanjie, the Company's controlling shareholder, actual controller, and chairman;
Proposal Right: Yes;
Proposal Date: June 4, 2026.

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.